Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study
verfasst von:
Christopher Uhlig, Ary Serpa Neto, Meta van der Woude, Thomas Kiss, Jakob Wittenstein, Benjamin Shelley, Helen Scholes, Michael Hiesmayr, Marcos Francisco Vidal Melo, Daniele Sances, Nesil Coskunfirat, Paolo Pelosi, Marcus Schultz, Marcelo Gama de Abreu, LAS VEGAS# investigators, Protective Ventilation Network (PROVEnet), Clinical Trial Network of the European Society of Anaesthesiology
Intraoperative mechanical ventilation may influence postoperative pulmonary complications (PPCs). Current practice during thoracic surgery is not well described.
Methods
This is a post-hoc analysis of the prospective multicenter cross-sectional LAS VEGAS study focusing on patients who underwent thoracic surgery. Consecutive adult patients receiving invasive ventilation during general anesthesia were included in a one-week period in 2013. Baseline characteristics, intraoperative and postoperative data were registered. PPCs were collected as composite endpoint until the 5th postoperative day. Patients were stratified into groups based on the use of one lung ventilation (OLV) or two lung ventilation (TLV), endoscopic vs. non-endoscopic approach and ARISCAT score risk for PPCs. Differences between subgroups were compared using χ2 or Fisher exact tests or Student’s t-test. Kaplan–Meier estimates of the cumulative probability of development of PPC and hospital discharge were performed. Cox-proportional hazard models without adjustment for covariates were used to assess the effect of the subgroups on outcome.
Results
From 10,520 patients enrolled in the LAS VEGAS study, 302 patients underwent thoracic procedures and were analyzed. There were no differences in patient characteristics between OLV vs. TLV, or endoscopic vs. open surgery. Patients received VT of 7.4 ± 1.6 mL/kg, a PEEP of 3.5 ± 2.4 cmH2O, and driving pressure of 14.4 ± 4.6 cmH2O. Compared with TLV, patients receiving OLV had lower VT and higher peak, plateau and driving pressures, higher PEEP and respiratory rate, and received more recruitment maneuvers. There was no difference in the incidence of PPCs in OLV vs. TLV or in endoscopic vs. open procedures. Patients at high risk had a higher incidence of PPCs compared with patients at low risk (48.1% vs. 28.9%; hazard ratio, 1.95; 95% CI 1.05–3.61; p = 0.033). There was no difference in the incidence of severe PPCs. The in-hospital length of stay (LOS) was longer in patients who developed PPCs. Patients undergoing OLV, endoscopic procedures and at low risk for PPC had shorter LOS.
Conclusion
PPCs occurred frequently and prolonged hospital LOS following thoracic surgery. Proportionally large tidal volumes and high driving pressure were commonly used in this sub-population. However, large RCTs are needed to confirm these findings.
Trial registration
This trial was prospectively registered at the Clinical Trial Register (www.clinicaltrials.gov; NCT01601223; registered May 17, 2012.)
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ARISCAT Score
Assess Respiratory Risk in Surgical Patients in Catalonia Score
ESA
European Society of Anaesthesiology
FIO2
Fraction of inspired oxygen
LAS VEGAS
Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications
LOS
Length of stay
NMBAs
Neuromuscular blocking agents
OLV
Open lung ventilation
PBW
Predicted body weight
PEEP
Positive end-expiratory pressure
Pplat
Plateau pressure
PPCs
Postoperative pulmonary complications
PROVEnet
Protective Ventilation Network
TLV
Total lung ventilation
TOF
Train–of–four stimulation
SpO2
Peripheral oxygen saturation
STROBE
Strengthening the reporting of observational studies in epidemiology
VT
Tidal volume
Background
Approximately 234 million major surgical procedures are undertaken worldwide every year [1]. Among these, approximately 7 million patients develop major complications resulting in one million deaths during surgery or in-hospital stay, contributing to an estimated mortality rate after anesthesia of 34 per million [1, 2]. According to the ‘Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications’ (LAS VEGAS) trial, postoperative pulmonary complications (PPC) occur in a significant proportion of surgical patients [3]. However, since thoracic surgery requires a differentiated ventilatory approach, those patients were excluded from the primary analysis of the LAS VEGAS study. In thoracic surgery, conventional methods to prevent and treat hypoxemia during one lung ventilation (OLV) can be harmful to the lung tissue: high fraction of inspired oxygen (FIO2) and low (or no) positive end–expiratory pressure (PEEP) both can promote atelectasis, whereas high tidal volume (VT) can cause baro- and volutrauma [4]. The type of thoracic surgery (open or endoscopic) as well as the intraoperative mechanical ventilation settings may also influence PPCs.
Intraoperative mechanical ventilation with low VT, low driving pressure, and low to moderate PEEP improved postoperative lung function and even outcome in patients undergoing open abdominal surgery [5, 6]. When low VT was used in abdominal surgery, high PEEP combined with recruitment maneuvers, as compared to low PEEP without recruitment maneuvers, did not add to the protection against PPCs [7].
Anzeige
The present study aimed to characterize the current mechanical ventilation practice during general anesthesia for thoracic surgery, describe the incidence of PPCs, and investigate possible associations between type of surgery (open vs. endoscopic), type of ventilation (OLV or two lung ventilation) and risk for PPCs (low risk vs high) with the incidence of PPCs. We hypothesized that intraoperative mechanical ventilation, as recommended in the literature, namely with low VT, low driving pressure, and low to moderate PEEP [8], is not commonly used during thoracic surgery, and that the incidence of PPCs is higher in this surgical population than in non-thoracic surgery.
Methods
Study design and sites
The present work is a post hoc analysis of the ‘Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications’ (LAS VEGAS trial) [3]. The LAS VEGAS trial protocol was first approved by the institutional review board of the Academic Medical Center, Amsterdam, The Netherlands (W12_190#12.17.0227) and registered at clinicaltrials.gov (NCT01601223). The protocol of this trial was published elsewhere [9].
Study population and data collection
Consecutive adult patients receiving invasive ventilation during general anesthesia for elective or non–elective surgery were eligible for participation in the study, which ran for seven predefined days in each country, selected by the national coordinator, in the period between January 14th and March 4th, 2013. Patients were excluded from participation if they were aged < 18 years, or scheduled for pregnancy related surgery, surgical procedures outside the operating room, or procedures involving cardio-pulmonary bypass.
The patient database of the LAS VEGAS trial was searched for eligible patients who received either open thoracic surgery, thoracoscopic or thoracoscopy assisted surgery (both summarized as endoscopic surgery), with or without OLV. These data have not been considered in previous analyses.
Anzeige
Reasonable parameters of baseline characteristics, intraoperative data and preoperative risk factors for PPCs were identified from previous studies [10‐13]. During the intraoperative period, data describing ventilation settings and vital parameters, as well as episodes of hypoxia (SpO2 < 92%), use of recruitment maneuvers, airway pressure reduction, presence of expiratory flow limitation, hypotension (mean arterial pressure < 60 mmHg), use of vasoactive drugs, and new arrhythmias, was collected. Postoperative residual curarisation with neuromuscular blocking agents (NMBAs), defined as train–of–four stimulation (TOF) ratio < 0.9, was documented.
The definition of protective mechanical ventilation is still under debate. For this analysis it was based on recent recommendations [8, 14‐16]. Patients were considered to be have been protectively ventilated “as recommended” if PEEP ≥5 cmH2O and VT ≤ 8 ml/kg PBW during TLV [8, 14, 17], and PEEP ≥5 cmH2O and VT ≤ 5 ml/kg PBW during OLV [18‐20].
The occurrence of PPCs is presented as a collapsed composite of PPCs in the first five postoperative days. The following PPCs were scored daily from the day of surgery until hospital discharge or postoperative day 5: 1) need for supplementary oxygen (due to PaO2 < 60 mmHg or SpO2 < 90% in room air, excluding oxygen supplementation given as standard care or as continuation of preoperative therapy), 2) respiratory failure (PaO2 < 60 mmHg or SpO2 < 90% despite oxygen therapy, or need for non-invasive mechanical ventilation), 3) unplanned new or prolonged invasive or non–invasive mechanical ventilation, 4) acute respiratory distress syndrome, 5) pneumonia. Severe PPCs were defined as the occurrence of one or more of the complications 2–5. Patient data were anonymized before entry onto a password secured, web–based electronic case record form (OpenClinica, Boston, MA, USA).
Statistical analysis
Patients were stratified into groups based on: 1) use or not of OLV (OLV vs. only TLV); 2) use or not of an endoscopic approach (endoscopic vs. open); and 3) risk for PPC according to ARISCAT (low risk [ARISCAT < 26] vs. moderate-to-high risk [ARISCAT ≥26] Supplemental Table 2, Additional file 1). The ventilatory data, which were collected hourly, were first averaged for each patient according to the number of observations (median of the value). In a longitudinal analysis, this data is presented for the first, second, third, fourth and last hour of surgery. All data are presented for the whole population and for the subgroups. In-hospital length of stay (LOS) and in-hospital mortality was censored at postoperative day 28. Proportions are compared using χ2 or Fisher exact tests and continuous variables are compared using the Mann-Whitney U Test, as appropriate.
The distributions of combinations of tidal volume size and PEEP level are presented in scatter plots. Cut-offs of 6 ml/kg PBW for tidal volume, and 5 cmH2O for PEEP were chosen to form the matrices. These cut-offs were based on widely accepted values of each variable, or according to normal daily practice. The driving pressure was defined as plateau pressure (Pplat) minus the PEEP level.
Kaplan–Meier estimates of the cumulative probability of development of PPC and hospital discharge were performed. Cox proportional hazard models without adjustment for covariates were used to assess the effect of the subgroups on outcome. The proportionality assumption was tested with scaled Schoenfeld residuals. Adjustments for multiple comparisons were not performed and no assumption for missing data was done. Statistical significance was considered to be at two-sided p < 0.05. All analyses were performed with R version 3.4.1 (http://www.R-project.org/).
Results
From 10,520 patients enrolled in the LAS VEGAS study, 302 patients underwent thoracic procedures (Supplemental Figure 1, Additional file 1). Characteristics of patient and surgery are shown in Table 1. In this sub-population of 302 thoracic surgical patients, 55% (168/302) received OLV, 15.2% (46/302) were operated with an endoscopic approach and 87.4% (264/302) had moderate-to-high risk for PPCs.
Table 1
Pre-Operative Characteristics of the Patients According to Subgroups
All Patients
(n = 302)
OLV
(n = 168)
TLV
(n = 134)
p value
Endoscopic
(n = 46)
Open
(n = 256)
p value
Low Risk
(n = 38)
High Risk
(n = 264)
p value
Age, years
62.0 (50.0–70.8)
62.0 (50.0–70.0)
62.0 (47.2–71.0)
0.799
62.0 (49.8–70.8)
62.0 (50.0–70.2)
0.839
37.0 (28.2–46.0)
64.0 (54.8–71.2)
< 0.001
Male gender
181 (59.9)
101 (60.1)
80 (59.7)
0.941
23 (50.0)
158 (61.7)
0.135
17 (44.7)
164 (62.1)
0.040
BMI, kg/m2
25.6 (22.9–28.9)
25.7 (23.3–29.3)
25.4 (22.5–28.7)
0.398
25.1 (21.8–27.5)
25.7 (23.0–29.3)
0.129
23.1 (20.9–26.3)
25.8 (23.4–29.2)
0.010
ASA physical status
0.573
0.880
< 0.001
1
40 (13.3)
22 (13.1)
18 (13.5)
5 (11.1)
35 (13.7)
20 (54.1)
20 (7.6)
2
109 (36.2)
60 (35.7)
49 (36.8)
18 (40.0)
91 (35.5)
17 (45.9)
92 (34.8)
3
141 (46.8)
82 (48.8)
59 (44.4)
20 (44.4)
121 (47.3)
0 (0.0)
141 (53.4)
4
11 (3.7)
4 (2.4)
7 (5.3)
2 (4.4)
9 (3.5)
0 (0.0)
11 (4.2)
ARISCAT score
40.0 (27.0–49.5)
40.0 (27.0–47.0)
39.0 (27.0–50.0)
0.755
35.0 (27.0–43.0)
40.0 (27.0–50.0)
0.018
24.0 (24.0–24.0)
43.0 (27.0–50.0)
< 0.001
Functional status
Independent
270 (89.4)
153 (91.1)
117 (88.0)
0.536
43 (93.5)
227 (89.0)
0.438
36 (94.7)
234 (89.0)
Partially dependent
26 (8.6)
12 (7.1)
14 (10.5)
2 (4.3)
24 (9.4)
2 (5.3)
24 (9.1)
0.772
Totally dependent
5 (1.7)
3 (1.8)
2 (1.5)
1 (2.2)
4 (1.6)
0 (0.0)
5 (1.9)
Smoking
83 (27.5)
43 (25.6)
40 (29.9)
0.410
12 (26.1)
71 (27.7)
0.817
9 (23.7)
74 (28.0)
0.574
Transfusion (< 24 h)
6 (2.0)
2 (1.2)
4 (3.0)
0.411
0 (0.0)
6 (2.3)
0.595
0 (0.0)
6 (2.3)
1.000
Respiratory infection (< 30 d)
24 (7.9)
17 (10.1)
7 (5.2)
0.118
2 (4.3)
22 (8.6)
0.551
0 (0.0)
24 (9.1)
0.054
Recent MV (< 30 d)
8 (2.6)
5 (3.0)
3 (2.2)
1.000
0 (0.0)
8 (3.1)
0.612
0 (0.0)
8 (3.0)
0.602
Co-morbidities
COPD
54 (17.9)
35 (20.8)
19 (14.2)
0.133
6 (13.0)
48 (18.8)
0.352
1 (2.6)
53 (20.1)
0.005
Apnea
5 (1.7)
1 (0.6)
4 (3.0)
0.174
1 (2.2)
4 (1.6)
0.564
0 (0.0)
5 (1.9)
1.000
Liver cirrhosis
2 (0.7)
2 (1.2)
0 (0.0)
0.504
0 (0.0)
2 (0.8)
1.000
0 (0.0)
2 (0.8)
1.000
Chronic kidney failure
7 (2.3)
5 (3.0)
2 (2.0)
0.468
1 (2.2)
6 (2.3)
1.000
0 (0.0)
7 (2.7)
0.601
Heart failure
23 (7.6)
9 (5.4)
14 (10.4)
0.097
2 (4.3)
21 (8.2)
0.548
0 (0.0)
23 (8.7)
0.092
Neuro disease
8 (2.6)
5 (5.0)
3 (2.2)
1.000
2 (4.3)
6 (2.3)
0.350
2 (5.3)
6 (2.3)
0.265
Laboratorial tests and vital signs
SpO2, %
97.0 (95.0–98.0)
97.0 (95.0–98.0)
97.0 (95.0–98.0)
0.347
98.0 (95.0–99.0)
97.0 (95.0–98.0)
0.232
98.0 (97.0–99.0)
97.0 (95.0–98.0)
< 0.001
Hemoglobin, g/dL
13.5 (12.4–14.8)
13.5 (12.4–14.5)
13.4 (12.5–15.0)
0.700
13.3 (12.9–14.6)
13.6 (12.3–14.8)
0.773
14.3 (13.3–15.2)
13.4 (12.3–14.6)
0.002
WBC, cell/mm3
7150.0 (6000.0–9000.0)
7000.0 (6000.0–9000.0)
7565.0 (6000.0–9150.0)
0.755
8000.0 (6000.0–9912.5)
7000.0 (6000.0–9000.0)
0.344
7000.0 (6000.0–8125.0)
7300.0 (6000.0–9000.0)
0.506
Surgical characteristics
Procedurea
Vascular
2 (0.7)
0 (0.0)
2 (1.5)
0.196
0 (0.0)
2 (0.8)
1.000
0 (0.0)
2 (0.8)
1.000
Cardiac
12 (4.0)
0 (0.0)
12 (9.0)
< 0.001
1 (2.2)
11 (4.3)
0.700
0 (0.0)
12 (4.5)
0.374
Lung / Pleural
231 (76.5)
152 (90.5)
79 (59.0)
< 0.001
34 (73.9)
197 (77.0)
0.654
27 (71.1)
204 (77.3)
0.397
Other
64 (21.2)
21 (12.5)
43 (32.1)
< 0.001
11 (23.9)
53 (20.7)
0.623
12 (31.6)
52 (19.7)
0.093
Condition
Elective
283 (93.7)
160 (95.2)
123 (91.8)
0.454
41 (91.3)
241 (94.1)
0.148
36 (94.7)
247 (93.6)
Urgency
13 (4.3)
5 (3.0)
8 (6.0)
4 (8.7)
9 (3.5)
2 (5.3)
11 (4.2)
0.856
Emergency
6 (2.0)
3 (1.8)
3 (2.2)
0 (0.0)
6 (2.3)
0 (0.0)
6 (2.3)
Planned duration
≤ 2 h
136 (45.0)
73 (43.5)
63 (47.0)
0.427
28 (60.9)
108 (42.2)
0.061
30 (78.9)
106 (40.2)
2–3 h
95 (31.5)
58 (34.5)
37 (27.6)
11 (23.9)
84 (32.8)
6 (15.8)
89 (33.7)
< 0.001
> 3 h
71 (23.5)
37 (22.0)
34 (25.4)
7 (15.2)
64 (25.0)
2 (5.3)
69 (26.1)
Antibiotic prophylaxis
266 (88.1)
146 (86.9)
120 (89.6)
0.480
38 (82.6)
228 (89.1)
0.213
27 (71.1)
239 (90.5)
< 0.001
Epidural anesthesia
72 (23.8)
48 (28.6)
24 (17.9)
0.307
5 (10.9)
67 (26.2)
0.024
4 (10.5)
68 (25.8)
0.039
Type of tube
Endotracheal
84 (27.8)
11 (6.5)
73 (54.5)
< 0.001
24 (52.2)
60 (23.4)
0.001
15 (39.5)
69 (26.1)
Bronchus blocker
19 (6.3)
12 (7.1)
7 (5.2)
1 (2.2)
18 (7.0)
2 (5.3)
17 (6.4)
0.295
SGA
6 (2.0)
2 (1.2)
4 (3.0)
0 (0.0)
6 (2.3)
1 (2.6)
5 (1.9)
DLT
193 (63.9)
143 (85.1)
50 (37.3)
21 (45.7)
172 (67.2)
20 (52.6)
173 (65.5)
Duration of surgery, min
105.0 (55.0–174.2)
104.0 (57.5–164.8)
105.0 (55.0–180.0)
0.836
62.5 (45.0–131.2)
110.0 (62.2–180.0)
0.003
55.0 (41.2–80.0)
115.0 (62.2–180.8)
< 0.001
Duration of anesthesia, min
145.0 (90.0–225.0)
147.5 (97.8–225.0)
145.0 (90.0–235.0)
0.651
105.0 (80.0–153.8)
152.0 (100.0–236.0)
0.001
88.0 (64.5–120.0)
160.0 (100.0–240.0)
< 0.001
Values are presented as median (interquartile range) or number (percentage). p values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney U Test for continuous variables
ARISCAT: ASA American Society of Anesthesiology recommended physical status, BMI Body mass index, COPD Chronic obstructive pulmonary disease, DLT Double-lumen tube, MV Mechanical ventilation, OLV One-lung ventilation, SGA Supraglottic airway, SpO2 Pulse oximetry, TLV Total lung ventilation, WBC White blood count;
amore than one option allowed
Characteristics of patients undergoing procedures with OLV vs. TLV, and endoscopic vs. open were comparable. Patients with moderate-to-high risk for PPCs were different from those at low risk with respect to age, gender, BMI, ASA status, COPD prevalence and planned duration of surgery (Table 1).
Anzeige
Intra-operative characteristics
Patients operated under OLV received more often double-lumen tubes and had more frequently lung or pleural surgery than those operated under TLV (Table 1). Use of epidural anesthesia was less and duration of surgery shorter in endoscopic compared to non-endoscopic surgery (Table 1).
Patients at moderate-to-high risk for PPC received more frequently antibiotic prophylaxis and epidural anesthesia, and had longer duration of surgery as well as anesthesia, compared with patients at low risk (Table 1).
The amounts of crystalloids, colloids, albumin and packed red blood cells was higher in open vs. endoscopic surgery, and in patients at moderate-to-high vs. low risk for PPC (Table 2).
Table 2
Intra-Operative Characteristics of the Patients According to Subgroups
All Patients
(n = 302)
OLV
(n = 168)
TLV
(n = 134)
p value
Endoscopic
(n = 46)
Open
(n = 256)
p value
Low Risk
(n = 38)
High Risk
(n = 264)
p value
Ventilation and vital signs
Ventilatory mode
Volume controlled
209 (70.8)
121 (73.3)
88 (67.7)
0.055
28 (65.1)
181 (71.8)
0.285
32 (91.4)
177 (68.1)
Pressure controlled
51 (17.3)
28 (17.0)
23 (17.7)
7 (16.3)
44 (17.5)
2 (5.7)
49 (18.8)
Pressure support
3 (1.2)
3 (1.8)
0 (0.0)
0 (0.0)
3 (1.2)
0 (0.0)
3 (1.2)
0.109
Spontaneous
8 (2.7)
1 (0.6)
7 (5.4)
3 (7.0)
5 (2.0)
0 (0.0)
8 (3.1)
Other
24 (8.1)
12 (7.3)
12 (9.2)
5 (11.6)
19 (7.5)
1 (2.9)
23 (8.8)
VT, ml
472.2 (400.5–525.0)
453.5 (398.4–510.0)
475.0 (430.6–549.0)
0.015
468.8 (400.0–544.5)
472.2 (405.6–525.0)
0.895
483.2 (443.1–543.9)
468.5 (400.0–525.0)
0.102
VT, ml/kg PBWa
7.6 (6.3–8.4)
7.4 (6.0–8.3)
7.6 (6.6–8.5)
0.050
7.6 (6.2–8.8)
7.5 (6.3–8.3)
0.225
7.6 (7.0–8.3)
7.5 (6.2–8.4)
0.587
Peak pressure, cmH2Oa
20.0 (17.5–24.0)
21.0 (18.0–25.0)
19.0 (16.0–23.0)
0.001
20.0 (16.2–23.0)
20.0 (18.0–24.0)
0.187
18.5 (15.6–22.0)
20.0 (18.0–24.1)
0.068
Plato pressure, cmH2Oa
17.8 (15.0–21.0)
18.2 (16.0–21.4)
16.5 (13.1–20.0)
0.004
16.0 (12.5–20.2)
18.0 (15.0–21.0)
0.118
15.8 (13.0–18.9)
18.0 (15.5–21.0)
0.010
PEEP, cmH2Oa
4.0 (1.5–5.0)
4.5 (2.4–5.0)
3.0 (1.5–5.0)
0.006
3.0 (1.5–5.0)
4.0 (2.0–5.0)
0.176
2.0 (0.0–5.0)
4.0 (2.0–5.0)
0.008
Driving pressure, cmH2Oa
14.0 (11.0–17.0)
14.5 (12.0–17.5)
13.0 (10.5–16.0)
0.016
13.0 (10.8–16.0)
14.0 (11.5–17.0)
0.389
14.0 (10.5–16.0)
14.0 (11.5–17.0)
0.216
Respiratory rate, bpm
12.0 (12.0–14.0)
12.0 (12.0–15.0)
12.0 (12.0–14.0)
0.128
12.0 (11.1–14.4)
12.0 (12.0–14.0)
0.715
12.0 (12.0–13.5)
12.0 (12.0–14.5)
0.644
FiO2, %
65.0 (50.0–80.0)
65.8 (50.0–85.0)
63.5 (50.0–80.0)
0.294
70.0 (58.5–83.6)
64.5 (50.0–80.0)
0.151
68.2 (50.0–75.0)
65.0 (50.0–84.0)
0.543
SpO2, %
99.0 (97.5–100.0)
98.5 (97.0–100.0)
99.0 (98.0–100.0)
0.039
99.0 (98.0–99.9)
99.0 (97.5–100.0)
0.724
99.0 (98.0–100.0)
99.0 (97.5–100.0)
0.352
MAP, mmHg
78.0 (71.0–86.6)
78.0 (71.0–86.0)
78.0 (71.0–88.0)
0.940
80.8 (74.0–95.0)
77.5 (70.0–85.0)
0.009
77.5 (71.5–91.6)
78.0 (71.0–86.0)
0.474
Heart rate, bpm
73.5 (64.5–82.0)
73.5 (64.5–82.5)
73.5 (65.0–81.1)
0.893
73.2 (65.2–79.0)
74.0 (64.5–82.0)
0.663
75.0 (70.0–81.5)
73.5 (63.6–82.0)
0.223
RM
105 (34.8)
71 (42.3)
34 (25.4)
0.002
13 (28.3)
92 (35.9)
0.314
7 (18.4)
98 (37.1)
0.023
In the last hour
68 (22.5)
52 (31.0)
16 (11.9)
< 0.001
6 (13.0)
62 (24.2)
0.094
2 (5.3)
66 (25.0)
0.006
Number of RM
0.0 (0.0–1.0)
0.0 (0.0–1.0)
0.0 (0.0–0.8)
0.003
0.0 (0.0–1.0)
0.0 (0.0–1.0)
0.397
0.0 (0.0–0.0)
0.0 (0.0–1.0)
0.020
Protective ventilation
41 (14.8)
13 (8.3)
28 (23.5)
< 0.001
10 (24.4)
31 (13.2)
0.091
4 (11.4)
37 (15.4)
0.798
Anesthesia characteristics
Type of anesthesia
TIVA
56 (18.5)
25 (14.9)
31 (23.1)
0.012
10 (21.7)
46 (18.0)
0.287
6 (15.8)
50 (18.9)
Volatile
188 (62.3)
117 (69.6)
71 (53.0)
31 (67.4)
157 (61.3)
22 (57.9)
166 (62.9)
0.483
Mixed
58 (19.2)
26 (15.5)
32 (23.9)
5 (10.9)
53 (20.7)
10 (26.3)
48 (18.2)
Opioids
Short acting
66 (21.9)
39 (23.2)
27 (20.3)
0.151
14 (30.4)
52 (20.4)
0.306
11 (28.9)
55 (20.9)
Long acting
202 (66.9)
106 (63.1)
96 (72.2)
28 (60.9)
174 (68.2)
24 (63.2)
178 (67.7)
0.475
Both
33 (10.9)
23 (13.7)
10 (7.5)
4 (8.7)
29 (11.4)
3 (7.9)
30 (11.4)
Total Fluids
Crystalloids, ml
1000.0 (875.0–2000.0)
1000.0 (1000.0–1750.0)
1000.0 (800.0–2000.0)
0.949
900.0 (500.0–1100.0)
1130.0 (1000.0–2000.0)
< 0.001
1000.0 (670.0–1000.0)
1100.0 (1000.0–2000.0)
< 0.001
Colloids, ml
500.0 (67.5–700.0)
500.0 (0.0–500.0)
500.0 (500.0–1000.0)
0.076
0.0 (0.0–500.0)
500.0 (450.0–850.0)
0.027
0.0 (0.0–500.0)
500.0 (500.0–1000.0)
0.007
Albumin, ml
0.0 (0.0–0.0)
0.0 (0.0–0.0)
0.0 (0.0–12.2)
0.755
0.0 (0.0–0.0)
0.0 (0.0–0.0)
0.212
0.0 (0.0–0.0)
0.0 (0.0–0.0)
0.134
PRBC, units
0.0 (0.0–2.0)
0.0 (0.0–1.0)
1.0 (0.0–2.0)
0.162
0.0 (0.0–0.0)
0.0 (0.0–2.0)
0.045
0.0 (0.0–0.0)
0.0 (0.0–2.0)
0.017
Reversal of NMBA
115 (38.1)
72 (43.1)
43 (32.1)
0.050
16 (34.8)
99 (38.8)
0.603
14 (36.8)
101 (38.4)
0.853
Values are presented as median (interquartile range) or number (percentage). p values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney U Test for continuous variables bpm beats per minute, etCO2 End-tidal carbon dioxide, FiO2 Inspired fraction of oxygen, MAP Mean arterial pressure, mpm Movements per minute, NMBA Neuromuscular blocking agents, OLV One lung ventilation, PBW Predicted body weight, PEEP Positive end-expiratory pressure, PRBC Packed red blood cells, RM Recruitment maneuver, SpO2 Pulse oximetry, TIVA Total intravenous anesthesia, TLV Total lung ventilation, VT Tidal volume
adata presented as the median used through surgery
Mechanical ventilation
Patients were ventilated with VT of 7.4 ± 1.6 ml/kg PBW, PEEP of 3.5 ± 2.4 cmH2O, and driving pressure of 14.4 ± 4.6 cmH2O (Table 2). Compared to patients operated solely under TLV, patients receiving OLV had lower VT, higher peak, plateau and driving pressures, as well as PEEP and respiratory rate, and received higher number of recruitment maneuvers (Table 2). Protective ventilation was used in 14.8% (41/302) of all patients, mainly during TLV. The ventilatory management of patients undergoing endoscopic and non-endoscopic procedures did not differ significantly. Patients at moderate-to-high risk for PPC had higher levels of PEEP, and received more recruitment maneuvers than patients at low risk (Table 2).
Anzeige
Values of ventilator settings along time are shown in Supplemental Figures 2 through 4 (Additional file 1). Patients operated under OLV had higher FiO2 compared with patients operated under TLV (Supplemental Figure 2, Additional file 1). The combinations of VT and PEEP according to subgroups are shown in Supplemental Figures 5 through 7 (Additional file 1).
Primary outcome
The overall incidence of PPCs in this population was 45.7% (138/302), and did not differ significantly between OLV vs. TLV (82/168 vs. 56/134, 48.8% vs. 41.8%, p = 0.223, total number and percentage respectively), and endoscopic vs. open procedures (16/46 vs. 122/256, 34.8% vs. 47.7%, p = 0.106, total number and percentage respectively, Table 3, Fig. 1). Patients at moderate-to-high risk showed an increased incidence of PPC compared to patients at lower risk (48.1% vs. 28.9%; hazard ratio, 1.95; 95% CI 1.05–3.61; p = 0.033), mainly due to unplanned need for supplemental oxygen (Table 3, Fig. 1).
Table 3
Clinical Outcomes of the Patients According to Subgroups
All Patients
(n = 302)
OLV
(n = 168)
TLV
(n = 134)
p value
Endoscopic
(n = 46)
Open
(n = 256)
p value
Low Risk
(n = 38)
High Risk
(n = 264)
p value
Primary outcome
PPC
138 (45.7)
82 (48.8)
56 (41.8)
0.223
16 (34.8)
122 (47.7)
0.106
11 (28.9)
127 (48.1)
0.026
Need of oxygen
109 (36.1)
65 (38.9)
44 (32.8)
0.274
12 (26.1)
97 (38.0)
0.120
8 (21.1)
101 (38.4)
0.037
Respiratory failure
26 (8.6)
15 (8.9)
11 (8.2)
0.824
1 (2.2)
25 (9.8)
0.148
2 (5.3)
24 (9.1)
0.755
Invasive MV
26 (8.6)
14 (8.3)
12 (9.0)
0.848
3 (6.5)
23 (9.0)
0.778
1 (2.6)
25 (9.5)
0.222
NIV
15 (5.0)
10 (6.0)
5 (3.7)
0.377
2 (4.3)
13 (5.1)
1.000
1 (2.6)
14 (5.3)
0.702
ARDS
4 (1.3)
4 (2.4)
0 (0.0)
0.132
0 (0.0)
4 (1.6)
1.000
0 (0.0)
4 (1.5)
1.000
Pneumonia
8 (2.6)
6 (3.6)
2 (1.5)
0.307
2 (4.3)
6 (2.3)
0.350
1 (2.6)
7 (2.7)
1.000
Secondary outcomes
Severe PPCa
53 (17.5)
30 (17.9)
23 (17.2)
0.875
7 (15.2)
46 (18.0)
0.651
4 (10.5)
49 (18.6)
0.223
Intra-OP complications
Desaturation
61 (20.2)
38 (22.6)
23 (17.2)
0.240
7 (15.2)
54 (21.1)
0.360
5 (13.2)
56 (21.2)
0.247
Unplanned RM
48 (15.9)
31 (18.5)
17 (12.7)
0.173
7 (15.2)
41 (16.0)
0.891
3 (7.9)
45 (17.0)
0.149
Pressure reduction
36 (11.9)
27 (16.1)
9 (6.7)
0.012
5 (10.9)
31 (12.1)
0.811
2 (5.3)
34 (12.9)
0.281
Flow limitation
3 (1.0)
2 (1.2)
1 (0.8)
1.000
0 (0.0)
3 (1.2)
1.000
0 (0.0)
3 (1.1)
1.000
Hypotension
102 (33.8)
60 (35.7)
42 (31.3)
0.424
8 (17.4)
94 (36.7)
0.010
3 (7.9)
99 (37.5)
< 0.001
Vasopressors
113 (37.4)
65 (38.7)
48 (35.8)
0.608
13 (28.3)
100 (39.1)
0.163
3 (7.9)
110 (41.7)
< 0.001
New arrhythmias
6 (2.0)
3 (1.8)
3 (2.2)
1.000
0 (0.0)
6 (2.3)
0.595
0 (0.0)
6 (2.3)
1.000
ICU admissionb
6 (2.0)
2 (1.2)
4 (3.0)
0.411
0 (0.0)
6 (2.3)
0.595
0 (0.0)
6 (2.3)
1.000
Hospital LOS, days
6.0 (3.0–10.0)
6.0 (4.0–11.0)
5.0 (3.0–9.0)
0.010c
3.0 (1.0–7.5)
6.0 (4.0–10.0)
< 0.001c
4.0 (1.0–6.0)
6.0 (4.0–10.0)
< 0.001c
Hospital mortality
1 (0.3)
1 (0.6)
0 (0.0)
1.000
0 (0.0)
1 (0.4)
1.000
0 (0.0)
1 (0.4)
1.000
Values are presented as median (interquartile range) or number (percentage). p values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney U Test for continuous variables ARDS Acute respiratory distress syndrome, ICU Intensive care unit, Intra-OP Intraoperative, LOS Length of stay, MV Mechanical ventilation, NIV Non-invasive ventilation, OLV One lung ventilation, PPC Postoperative pulmonary complication, RM Recruitment maneuvers, TLV Total lung ventilation
aexcluding need of oxygen
bunplanned admission
cp value from the Cox proportional hazard model
×
Secondary outcomes
The incidence of severe PPCs, unplanned ICU admission and hospital mortality did not differ among groups (Table 3). The incidence of hypotension was decreased in endoscopic compared to open procedures, and in patients at lower compared to moderate-to-high risk of PPCs (Table 3).
The LOS was increased in patients who developed PPCs (Supplemental Figure 8, Additional file 1), and shorter in patients operated under OLV vs. TLV, endoscopic vs. open, and those with low vs. moderate-to-high risk for PPC (Table 3, Fig. 2).
×
Anzeige
Discussion
In this population of patients undergoing thoracic surgery: 1) mechanical ventilation differed from those recommended for lung protection in 85.2% of all patients; 2) patients under OLV received lower VT, higher peak, plateau and driving pressures, higher PEEP levels and respiratory rate, and received more recruitment maneuvers compared with TLV; 3) the overall incidence of PPCs was as high as 45.7%; 4) PPCs were more common among patients with higher ARISCAT score or co-morbidities, but not increased following open vs. endoscopic procedures, or OLV vs. TLV; 6) PPCs were associated with increased LOS.
To our knowledge, this is the first prospective observational investigation addressing the practice of mechanical ventilation and incidence of PPCs in thoracic anesthesia. The main strengths of our study are that data was stored, analyzed and reported according to international standards [21].
High VT strategies, usually accompanied by low or zero PEEP, have been used to prevent intraoperative atelectasis [22, 23]. However, this may cause overdistension (volutrauma), and repetitive collapse-reopening of lung units (atelectrauma), which can injure the lungs and lead to PPCs [24]. A protective ventilation approach consisting mainly of low VT reduces the incidence of PPCs [7, 25]. This seems to apply also to thoracic anesthesia but this claim is not undisputed [26‐28]. The present study shows that protective mechanical ventilation, as recommended, was used in less than 15% of patients undergoing thoracic surgery. Different possible reasons might explain this finding: 1) the concept of protective ventilation during surgery is still not widespread among anesthesiologists; 2) the role of single components of mechanical ventilation in lung protection, especially of PEEP, is still poorly defined, leading anesthesiologists to set values according to their own preferences; 3) sound evidence from large RCTs demonstrating the benefit of protective mechanical ventilation in thoracic surgical patients is still missing; 4) thoracic surgical procedures usually last less than 1 hour, which might be deemed as too short to benefit from protective mechanical ventilation; 5) mechanical ventilation settings guided by driving pressure may result in VT and PEEP outside the range that has been recommended for protective mechanical ventilation.
The incidence of PPCs after surgery is influenced by patient-related factors, and type of surgery. In a mixed surgical population without surgery involving cardiopulmonary bypass, 10.4% of patients developed PPCs within the first postoperative 5 days; values ranged from 6.7% in plastic/cutaneous procedures to 38.2% in transplant surgery [3]. In open abdominal surgery, PPCs were reported in 10.5 to 39.0% of patients, despite the use of a protective ventilation strategy [3, 7, 25]. In average, 10.7% of patients at increased risk, for example obese patients, developed PPCs [29]. In patients undergoing thoracic surgery, an incidence of PPCs between 10.7 and 50% has been reported [26, 30‐32]. This relatively wide range is possibly explained by differences in definition of pulmonary complications among trials. The rate of severe PPCs was 17.5% in our thoracic surgery population, which is comparable to the rate of 18.1% reported by Blank and colleagues [26].
The observation that patients who developed PPCs had more comorbidities and longer LOS is in line with previous studies addressing intraoperative TLV [3, 33]. The difference in LOS in the subgroups is likely explained by the type of procedure per se, where open approaches require a prolonged treatment due to more complex procedures, independent from the type of mechanical ventilation.
Although the incidence of PPCs was relatively high, neither open thoracic surgery procedures, nor OLV itself were associated with them, especially when taking the infrequent use of protective mechanical ventilation in this population into account. The precise role of PEEP for protective intraoperative mechanical ventilation has been challenged in recent trials [7, 34]. In fact, it has been suggested that a strategy aimed at permissive atelectasis might be as protective as a strategy to open lungs during surgery [14, 35]. Our finding that higher VT was not associated with PPCs is intriguingly, but in agreement with data from an observational study reporting that the use of VT as high as 8 mL/kg as even associated with better pulmonary outcome [26]. Together, these findings suggest that protective OLV settings are more complex than previously thought. Cutoff values, although valuable, must not only consider the interaction among variables, but also a possible role of airway pressures.
Limitations
This study has several limitations. First, a one-week inclusion period was relatively short in order to include a high number of patients per center. However, this fact was counterbalanced by the multicenter design. Second, a short inclusion period might have resulted in selection bias, since fluctuation of the severity of cases cannot be ruled out. Nevertheless, the benefits of avoiding changes in therapy during the observation period as a potential confounder should not be underestimated. Third, the definition of protective mechanical ventilation was based on recommendations that are still under debate. Fourth, most study sites included less than 10 patients. This number, however, does not imply lack of experience with the procedure, since thoracic anesthesia per se already requires a substantial degree of expertise. Fifth, the duration of OLV was not investigated and, therefore, the exact contribution of OLV to PPCs cannot be separated from the period under TLV in this sub-population. Sixth, the design of this study precludes the possibility of determining cause-effect relationships, and results must be seen from a hypothesis-generating perspective. Seventh, the fact that data was collected prospectively might have interfered with clinical practice itself, and biased towards the use of protective ventilation. Still, non-protective ventilation was used in a vast majority of patients. Eighth, the total number of patients enrolled allowed analyses of three subgroups only. Potential confounders could be the type of anesthesia (total intravenous anesthesia vs. volatile anesthetics), the type of postoperative analgesia (epidural anesthesia vs. opioids) or the ASA status, which should be subject of future trials.
Conclusions
The present study provides relevant insight into the practice of mechanical ventilation during thoracic surgery. The data might prove useful for the development of scores for risk prediction in this particular population, allocation of human and financial resources, including need for postoperative monitoring in dedicated units, and also estimation of sample size in interventional trials [18]. Mechanical ventilation practice did not follow current recommendations for lung protection in the vast majority of patients undergoing thoracic surgery. Although PPCs were common in this population, and associated with increased LOS, their incidence was not higher following open vs. endoscopic or OLV vs. TLV, and not associated with mechanical ventilation settings. It must be emphasized that the lack of association between mechanical ventilation settings and PPCs does not support use of non-protective VT and PEEP in this population.
The authors thank the European Society of Anaesthesiology (ESA) for co–sponsoring and endorsement as well as assistance in developing and hosting of the electronic case record forms, database and recruiting study sites.
The LAS VEGAS Study Collaborators
Collaborators are listed in the supplemental material (Additional file 1, pp. 2–5).
Ethics approval and consent to participate
The trial protocol was first approved by the institutional review board of the Academic Medical Center, Amsterdam, The Netherlands (W12_190#12.17.0227). Written informed consent was obtained from all participants prior to trial enrollment.
Consent for publication
Not applicable.
Competing interests
All authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study
verfasst von
Christopher Uhlig Ary Serpa Neto Meta van der Woude Thomas Kiss Jakob Wittenstein Benjamin Shelley Helen Scholes Michael Hiesmayr Marcos Francisco Vidal Melo Daniele Sances Nesil Coskunfirat Paolo Pelosi Marcus Schultz Marcelo Gama de Abreu LAS VEGAS# investigators, Protective Ventilation Network (PROVEnet), Clinical Trial Network of the European Society of Anaesthesiology
Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.
Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.
Update AINS
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.